Overview Guidelines for PET scans in diagnosing AD – Gil Rabinovici Monitoring patients on anti-amyloid antibodies – Liana Apostolova ...
AD
Overview Fluid biomarkers Presentation Summaries When it comes to fluid-based biomarkers, those measured in the cerebrospinal fluid (CSF) still...
Overview Donanemab Other Presentation Summaries As the first true disease-modifying therapy (DMT), lecanamab has the potential to revolutionize AD...
Overview Novel Therapeutics Presentation Summaries The approval of the anti-amyloid antibody lecanemab is an important first step in creating...
Editor’s note: many of the presentations on glia discussed connections with APOE. You can find coverage of those talks...
Overview APOE4: Presentation Summaries Understanding sporadic Alzheimer’s (sAD) requires understanding apolipoprotein E (APOE). No gene determines risk for sAD...
“Neuronal γ-secretase regulates lipid metabolism, linking cholesterol to synaptic dysfunction in Alzheimer’s disease.” Sofia Essayan-Perez and Thomas C. Südhof...
“CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease.” Kanta Horie, et al. – Washington...
“Alzheimer’s disease associated isoforms of human CD33 distinctively modulate microglial cell responses in 5XFAD mice.” Ghazaleh Eskandari-Sedighi, et al....
“CHRNA5 links chandelier cells to protection against amyloid pathology in human aging and Alzheimer’s Disease.” Jonas Rybnicek, et al....